Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ailmin
- Development stage
- Preclinical
- Administration
- Ophthalmic
01
Overview
Ailmin is a brand name for 0.1% sodium hyaluronate eye drops. Sodium hyaluronate is a naturally occurring polysaccharide that acts as a lubricant and moisturizer. It is used to relieve symptoms of dry eye by stabilizing the tear film and promoting corneal healing. It exhibits non-Newtonian properties, allowing it to lubricate effectively, and also has mucoadhesive properties.
- Brand names
- AilminAiermin
- Other names
- 0.1% sodium hyaluronate eye drops
Beyond the preview
Go deeper on Ailmin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ailmin.